As discussed above, the multifunctional roles of CD44 in dynamic interactions between tumors and the TME, as well as in the regulation of cancer metastasis, stemness, and chemoresistance make CD44 an attractive therapeutic target to improve clinical outcomes for ovarian cancer patients by sensitizing them to chemotherapy. The gene discussed is CD44; the disease is ovarian cancer.